BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23626764)

  • 21. The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines.
    Fujiwara D; Kato K; Nohara S; Iwanuma Y; Kajiyama Y
    Biochem Biophys Res Commun; 2013 May; 434(4):773-8. PubMed ID: 23602898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PCDH20 acts as a tumour-suppressor gene through the Wnt/β-catenin signalling pathway in hypopharyngeal squamous cell carcinoma.
    Gong Z; Hu G
    Cancer Biomark; 2019; 26(2):209-217. PubMed ID: 31450490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.
    Murillo-Sauca O; Chung MK; Shin JH; Karamboulas C; Kwok S; Jung YH; Oakley R; Tysome JR; Farnebo LO; Kaplan MJ; Sirjani D; Divi V; Holsinger FC; Tomeh C; Nichols A; Le QT; Colevas AD; Kong CS; Uppaluri R; Lewis JS; Ailles LE; Sunwoo JB
    Oncotarget; 2014 Aug; 5(16):6854-66. PubMed ID: 25149537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
    Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
    J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes.
    Morrison LC; McClelland R; Aiken C; Bridges M; Liang L; Wang X; Di Curzio D; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
    Neoplasia; 2013 Apr; 15(4):384-98. PubMed ID: 23555184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p75 neurotrophin receptor expression is a characteristic of the mitotically quiescent cancer stem cell population present in esophageal squamous cell carcinoma.
    Yamaguchi T; Okumura T; Hirano K; Watanabe T; Nagata T; Shimada Y; Tsukada K
    Int J Oncol; 2016 May; 48(5):1943-54. PubMed ID: 26984177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of microRNA‑194‑5p inhibits hypopharyngeal carcinoma cell proliferation, migration and invasion by targeting SMURF1 via the mTOR signaling pathway.
    Xu S; Hui L; Yang N; Wang Y; Zhao N; Jiang XJ
    Int J Oncol; 2019 Apr; 54(4):1245-1255. PubMed ID: 30720112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.
    Yu B; Wang Y; Yu X; Zhang H; Zhu J; Wang C; Chen F; Liu C; Wang J; Zhu H
    Int J Nanomedicine; 2017; 12():2553-2567. PubMed ID: 28435246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
    Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
    Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of claudin-1 and its relationship with lymphatic microvessel generation in hypopharyngeal squamous cell carcinoma.
    Li WJ; Zhang ZL; Yu XM; Cai XL; Pan XL; Yang XY
    Genet Mol Res; 2015 Oct; 14(4):11814-26. PubMed ID: 26436506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective autophagy leads to the suppression of stem-like features of CD271
    Zhang D; Zhao Q; Sun H; Yin L; Wu J; Xu J; He T; Yang C; Liang C
    J Biomed Sci; 2016 Nov; 23(1):82. PubMed ID: 27863492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.
    Huang SD; Yuan Y; Liu XH; Gong DJ; Bai CG; Wang F; Luo JH; Xu ZY
    BMC Cancer; 2009 Jan; 9():9. PubMed ID: 19134212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
    Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
    J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.
    Kuçi S; Kuçi Z; Kreyenberg H; Deak E; Pütsch K; Huenecke S; Amara C; Koller S; Rettinger E; Grez M; Koehl U; Latifi-Pupovci H; Henschler R; Tonn T; von Laer D; Klingebiel T; Bader P
    Haematologica; 2010 Apr; 95(4):651-9. PubMed ID: 20179086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
    Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
    Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin in hypopharyngeal carcinoma cells.
    Cao S; Yu Y; Chen S; Lei D; Wang S; Pan X; Peng J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):536-541. PubMed ID: 27847320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin induces stemness in ovarian cancer.
    Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O
    Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.
    Kumar SM; Liu S; Lu H; Zhang H; Zhang PJ; Gimotty PA; Guerra M; Guo W; Xu X
    Oncogene; 2012 Nov; 31(47):4898-911. PubMed ID: 22286766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD271
    Liang L; Coudière-Morrison L; Tatari N; Stromecki M; Fresnoza A; Porter CJ; Del Bigio MR; Hawkins C; Chan JA; Ryken TC; Taylor MD; Ramaswamy V; Werbowetski-Ogilvie TE
    Cancer Res; 2018 Aug; 78(16):4745-4759. PubMed ID: 29930101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.